Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.78
+0.41 (1.75%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $4.01 billion as of September 11, 2026. Its market cap has increased by 466.63% in one year.
Market Cap
4.01B
Enterprise Value
3.03B
1-Year Change
466.63%
Ranking
Category
Stock Price
$23.78
ChartMarket Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $4.01B, an increase of 2,465.19%. That is a compound annual growth rate of 82.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.01B | 236.02% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 4.41B |
| Enliven Therapeutics | 4.21B |
| Veradermics | 4.16B |
| Telix Pharmaceuticals | 4.09B |
| Relay Therapeutics | 4.09B |
| Legend Biotech | 3.86B |
| Iovance Biotherapeutics | 3.82B |
| Viking Therapeutics | 3.81B |